| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/13/2010 | CN101624580A Recombinant baculovirus expressing manually modified and synthesized influenza A H1N1 virus HA-NA-M1 gene |
| 01/13/2010 | CN100580080C Corona-virus-like particles comprising functionally deleted genomes |
| 01/12/2010 | US7647184 High throughput directed evolution by rational mutagenesis |
| 01/12/2010 | US7645599 Specific, asymmetric reduction of 3-quinuclidinone using tropinone reductase-I in the presence of a reduced coenzyme to produce (R)-3-quinuclidinol; high optical purity |
| 01/12/2010 | US7645455 Chimeric lyssavirus nucleic acids and polypeptides |
| 01/12/2010 | CA2272845C Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 01/12/2010 | CA2170412C Modified plant viruses as vectors of heterologous peptides |
| 01/12/2010 | CA2144674C Use of azoles as virucidal agents in solutions of biologically active proteins |
| 01/07/2010 | US20100004162 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof |
| 01/07/2010 | US20100003262 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 01/07/2010 | US20100003233 Compositions and methods for treatment of microbial infections |
| 01/07/2010 | US20100003221 Medium Supplement for Virus Production |
| 01/07/2010 | US20100003220 Agents for treating malignant mesothelioma |
| 01/07/2010 | US20100003215 Culturing circular ssDNA viruses for the production of vaccines |
| 01/07/2010 | US20100003214 Quinoxaline-containing compounds as hepatitis c virus inhibitors |
| 01/06/2010 | EP2140879A1 Composition and method for treating cancer using herpes virus |
| 01/06/2010 | EP1135468B1 Virus vectors and methods of making and administering the same |
| 01/06/2010 | CN101619306A Influenza B virus Vero cell productive adaptive strain and preparation and application thereof |
| 01/06/2010 | CN101618049A Treatment of neoplasms with viruses |
| 01/06/2010 | CN100577683C Infectious cDNA of an approved vaccine strain of measles virus, use for the same used as immunogenic compositions |
| 01/05/2010 | US7642049 Method for identifying HIV-1 protease inhibitors with reduced metabolic affects through detection of human resistin polymorphisms |
| 01/05/2010 | US7641909 Nonstructural and nonstructural proteins from attenuated dengue-2 virus, and structural protein from West Nile virus; vaccines |
| 01/05/2010 | CA2300480C Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 01/05/2010 | CA2260759C Recombinant swinepox virus |
| 01/05/2010 | CA2164835C Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 12/31/2009 | US20090326043 Method and Compound for Antiviral (HIV) Therapy |
| 12/31/2009 | US20090326019 3,4-bicyclic pyrrolidine antivirals |
| 12/31/2009 | US20090325815 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 12/31/2009 | US20090325269 Bacteria/RNA extraction device |
| 12/31/2009 | US20090325146 Method of determining susceptibility of a tumor cell to a chemotherapeutic agent: novel use of herpes |
| 12/31/2009 | US20090324702 Novel viral vector |
| 12/31/2009 | US20090324640 Neuraminidase-deficient live influenza vaccines |
| 12/31/2009 | US20090324632 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 12/31/2009 | US20090324551 Tlr agonists |
| 12/31/2009 | US20090324548 Clonal strain of attenuated vaccinia virus that can be used to prevent or treat small pox |
| 12/31/2009 | DE102008028406A1 In vitro method for the propagation and increase of norovirus comprises growing uninfected Vero cells in tissue culture bottle, separately suspending norovirus positive patients stool, filtering suspension and sucking growing medium |
| 12/30/2009 | WO2009158614A1 Novel astrovirus |
| 12/30/2009 | WO2009156448A1 Attenuated pestivirus |
| 12/30/2009 | WO2009156155A1 Cell line for propagation of highly attenuated alphaviruses |
| 12/30/2009 | WO2009131606A3 Viral inactivation using crosslinkers and detergents |
| 12/30/2009 | WO2009105084A3 Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof |
| 12/30/2009 | WO2009055491A3 Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres |
| 12/30/2009 | WO2008112344A3 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins |
| 12/30/2009 | CN101613679A Rhabdovirus with recombination superoxide dismutase gene and preparation and application thereof |
| 12/30/2009 | CA2729105A1 Attenuated pestivirus |
| 12/29/2009 | US7638608 Assay for the separation and quantification of hemagglutinin antigens |
| 12/29/2009 | US7638499 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 12/29/2009 | US7638319 useful in screening for small molecule inhibitors of X4 vs R5 viruses, for focusing antiviral therapies based on the predominant or exclusive type of HIV-1 virus present (X4 vs R5) and for creating templates for rational vaccine design |
| 12/29/2009 | US7638318 RNA picornavirus; selectively kills some types of tumors; making new oncolytic virus derivatives and of altering viruses to have tumor-specific tropisms |
| 12/29/2009 | US7638269 Viral capsid assembly intermediates and methods of production |
| 12/29/2009 | US7638132 genetically stable vaccinia viruses and vaccinia virus vectors with higher safety, which undergo reversion with difficulty because of the removal of a gene involved in reversion from an attenuated smallpox vaccinia virus LC16m8 strain or its parental LC16mO strain, which tends to undergo reverse mutation |
| 12/29/2009 | US7638120 High transgene expression of a pseudotyped adeno-associated virus type |
| 12/24/2009 | US20090317418 Vaccines and methods for prevention and treatment of drug-resistant hiv-1 and hepatitis b virus |
| 12/24/2009 | US20090317417 Modified AAV Vectors Having Reduced Capsid Immunogenicity and Use Thereof |
| 12/24/2009 | US20090317324 Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain |
| 12/23/2009 | WO2009155168A1 Method of replicating viruses in suspension cultures of dog kidney cells |
| 12/23/2009 | WO2009154452A1 Parvoviral capsid with incorporated Gly-Ala repeat region |
| 12/23/2009 | WO2009153518A2 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 12/23/2009 | WO2009152969A1 Recombinant modified vaccinia virus measles vaccine |
| 12/23/2009 | EP2134757A2 Imprinted polymeric materials for binding various targets such as viruses |
| 12/23/2009 | EP2134359A2 Use of an avirulent bordetella mutant as a live vaccine vector |
| 12/23/2009 | EP1575979B1 West nile virus vaccine |
| 12/23/2009 | EP1397499B1 Aav helper plasmids for helper virus-free packaging and pseudo typification of aav vectors |
| 12/23/2009 | EP1094837B1 Porcine circovirus and parvovirus vaccine |
| 12/23/2009 | CN101610787A Method for replicating influenza virus in culture |
| 12/23/2009 | CN100572532C Duck plague vaccines and special strains therefor |
| 12/23/2009 | CN100572531C Method for cultivating influenza virus |
| 12/23/2009 | CA2728233A1 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 12/23/2009 | CA2726513A1 Method of replicating viruses in suspension cultures of dog kidney cells |
| 12/22/2009 | US7635752 Ablated SLAM-Dependent Entry |
| 12/22/2009 | US7635666 Methods for producing members of specific binding pairs |
| 12/22/2009 | US7635584 E. coli O157:H7 bacteriophage and uses thereof |
| 12/22/2009 | CA2354024C A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 12/22/2009 | CA2181862C Mild newcastle disease virus vaccine |
| 12/17/2009 | WO2009152181A1 Cell-based systems for producing influenza vaccines |
| 12/17/2009 | WO2009151697A2 Compositions and processes relating to human bocavirus |
| 12/17/2009 | WO2009151313A1 A novel antiviral peptide against avian influenza virus h9n2 |
| 12/17/2009 | US20090312266 Peptide derived from vascular endothelial growth factor receptor-1 binding integrin alpha5beta1 having proangiogenic activity |
| 12/17/2009 | US20090312190 Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other Flaviviruses |
| 12/17/2009 | US20090311770 Method of collecting microorganisms using fine particles, method of collecting nucleic acids using fine particles, and kits for use in the these methods |
| 12/17/2009 | US20090311746 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 12/17/2009 | US20090311742 Phage-Derived Vectors and Methods for Protein Expression |
| 12/17/2009 | US20090311669 Signal for packaging of influenza virus vectors |
| 12/17/2009 | US20090311666 Microfluidic device for crystallization and crystallographic analysis of molecules |
| 12/17/2009 | US20090311284 Recombinant Viral Proteins And Particles |
| 12/17/2009 | US20090311219 Oncolytic Adenoviruses for Cancer Treatment |
| 12/16/2009 | EP2132315A1 Reoviruses having modified sequences |
| 12/16/2009 | EP1604020B1 Method to confer cell culture replication activity to different hepatitis c virus isolates |
| 12/16/2009 | EP1135469B1 An improved method for the production and purification of adenoviral vectors |
| 12/16/2009 | EP1114189B1 Recombinant newcastle disease virus rna expression systems and vaccines |
| 12/16/2009 | CN101605558A Influenza recombinant subunit vaccine |
| 12/16/2009 | CN101603035A Porcine reproductive and respiratory syndrome virus chimeric recombinant vaccine strain and method for producing living vaccine with same |
| 12/16/2009 | CN100569297C Gene transfer-mediated angiogenesis therapy |
| 12/16/2009 | CN100569286C Attenuated strains of vibrio cholerae with freeze-dry type and modified biological security for orally inoculability |
| 12/15/2009 | US7632637 long-chained alkyl amine immobilized on silica substrate, binding nucleic acid complexing agent (unsymmetrical cyanine dye configured to penetrate phage head and bind to nucleic acid therein), binding silanated amine to silica substrate, activating amine with dialdehyde, reacting with alkyl-amine |
| 12/15/2009 | US7632512 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections |
| 12/15/2009 | US7632509 Methods to express recombinant proteins from lentiviral vectors |
| 12/15/2009 | CA2439872C Leporipox-based vector vaccines |
| 12/15/2009 | CA2337965C Attenuated equine herpesvirus |
| 12/10/2009 | WO2009146867A1 Pestivirus replicons providing an rna-based viral vector system |